Biotech Company Cara Therapeutics (CARA) Up 15%

This article was originally published on

Despite the sea of red in U.S. markets today, one stock that has been showing stellar gain is biotech company Cara Therapeutics (CARA). Cara, a biotech that has been developing treatments for itchiness, rose 12.6% in pre-market trade Wednesday after the company released studies that dialysis patients experiencing itchiness who were given its Korsuva injection [...]

Read more at >